Iovance Biotherapeutics Reports Record Second Quarter 2026 Revenue of ~$99M, Business Achievements, and Corporate Updates
Go back to Iovance Biotherapeutics Reports Record Second Quarter 2026 Revenue of ~$99M, Business Achievements, and Corporate Updates| (NASDAQ: IOVA) | Delayed: 10.19 +0.32 (3.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.87 | 52 Week High | $ | |||
| Open | $10.25 | 52 Week Low | $ | |||
| Day High | $10.98 | P/E | N/A | |||
| Day Low | $10.15 | EPS | $ | |||
| Volume | 15,844,030 | |||||

